CELESTODERM V OINTMENT

국가: 캐나다

언어: 영어

출처: Health Canada

지금 구매하세요

제품 특성 요약 제품 특성 요약 (SPC)
29-09-2020

유효 성분:

BETAMETHASONE (BETAMETHASONE VALERATE)

제공처:

BAUSCH HEALTH, CANADA INC.

ATC 코드:

D07AC01

INN (International Name):

BETAMETHASONE

복용량:

0.1%

약제 형태:

OINTMENT

구성:

BETAMETHASONE (BETAMETHASONE VALERATE) 0.1%

관리 경로:

TOPICAL

패키지 단위:

450G

처방전 유형:

Prescription

치료 영역:

ANTI-INFLAMMATORY AGENTS

제품 요약:

Active ingredient group (AIG) number: 0106299001; AHFS:

승인 상태:

APPROVED

승인 날짜:

2014-10-10

제품 특성 요약

                                PRESCRIBING INFORMATION
PR
CELESTODERM
® V
Betamethasone valerate cream USP
Betamethasone valerate ointment USP
0.1%
PR
CELESTODERM
® V/2
Betamethasone valerate cream USP
Betamethasone valerate ointment USP
0.05%
TOPICAL CORTICOSTEROID
September
29
,
2020
DATE OF
REVISION:
Control
#:
242776
H7L 4A8
Laval, Quebec
2150 St-Elzear
Blvd. West
,
BAUSCH HEALTH, CANADA INC.
_ _
_Pr_
_CELESTODERM _
_®_
_ V and CELESTODERM_
_®_
_ V/2 Prescribing Information Page 2 of 10_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................4
WARNINGS AND
PRECAUTIONS…………………………………………………......4
ADVERSE REACTIONS
....................................................................................................7
DRUG INTERACTIONS
....................................................................................................7
DOSAGE AND ADMINISTRATION
................................................................................8
OVERDOSAGE
..................................................................................................................9
ACTION AND CLINICAL PHARMACOLOGY
..............................................................9
STORAGE AND STABILITY
............................................................................................9
DOSAGE FORMS, COMPOSITION AND PACKAGING
...............................................9
_ _
_Pr_
_CELESTODERM _
_®_
_ V and CELESTODERM_
_®_
_ V/2 Prescribing Information Page 3 of 10_ PR
CELESTODERM
® V
Betamethasone valerate cream USP
Betamethasone valerate ointment USP
0.1%
PR
CELESTODERM
® V/2
Betamethasone valerate cream USP
Betamethasone val
                                
                                전체 문서 읽기
                                
                            

다른 언어로 된 문서

제품 특성 요약 제품 특성 요약 프랑스어 29-09-2020

이 제품과 관련된 검색 알림